SCHEMBL14435191

SCHEMBL14435191

C=CCOC(=O)Cc1sc2ccc(Cl)cc2c1C

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.56
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
CMA1 P23946 3/20 0.38
PFKFB3 Q16875 6/20 0.38
PFKFB4 Q16877 6/20 0.38
TSHR P16473 2/20 0.37
GAA P10253 1/20 0.37
ROCK1 Q13464 1/20 0.37
SIRT1 Q96EB6 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tianafac SCHEMBL2109723 0.78 MAPT (0.67) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL4380469 0.73 MAPT (0.50) MAPTMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL7018255 0.72 MAPT (0.59) MAPTL3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL6984802 0.71 MAPT (0.54) MAPTKDM4EL3MBTL1CMA1PFKFB3
SCHEMBL10091955 0.70 MAPT (0.56) MAPTKDM4EL3MBTL1CMA1PFKFB3
SCHEMBL11256326 0.68 MAPT (0.54) MAPTKDM4EL3MBTL1CMA1PFKFB3
SCHEMBL6659125 0.68 MAPT (0.49) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL28895381 0.68 MAPT (0.45) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL14218140 0.68 MAPT (0.54) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL6627880 0.67 ALDH1A1 (0.43) MAPTMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007098356-A1 CONGENERS OF MILNACIPRAN AS MONOAMINE RE-UPTAKE NEUROCRINE BIOSCIENCES, INC. (US) 2007-08-30 WO disclosed